Two NIH institutes are allotting $24 million over four years to support research on the genotypic and phenotypic links between lung cancer and chronic obstructive pulmonary disease. Potential focus areas for research include identification and confirmation of biomarkers, molecular mechanisms and imaging procedures that could be used to further understand the diseases.

Related Summaries